24 completed, 5 terminated, 4 recruiting, 4 unknown. 9 Not applicable, 8 Phase 2, 6 Phase 4, 3 Phase 1, 3 Phase 3.
Follow Viremia: new trials by email Literature Review of Viremia trials Research Report on Viremia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 25BT056: Basket Study of Viral Cytotoxic T Lymphocytes Virus-Specific Cytotoxic T Lymphocytes (vCTLs) - EBV Viremia, CMV Viremia | Early Phase 1 | Not yet recruiting | Children's Hospital of Philadelphia | 35 | 2026-11-01 | 2026-10-22 |
| Adaptability of an Undetectable = Untransmissible Model for HBV Chronic Hepatitis b, Viremia | Recruiting | NYU Langone Health | 55 | 2026-05-01 | 2026-05-15 | |
| Safety, Virological and Immunological Assessment of the Controlled Dengue Human Infection Model in Dengue-Immune Participants in Thailand (DHIT-Immune) rDEN2Δ30-7169 - Safety Issues, Dengue | Early Phase 1 | Not yet recruiting | Mahidol University | 12 | 2025-09-01 | 2025-04-03 |
| Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV Enhanced Mentor Mother Strategy - Hiv, Transmission Vertical | Not applicable | Recruiting | Indiana University | 200 | 2025-07-10 | 2026-08-11 |
| Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT) Quantiferon CMV (assay that determine the presence of CMV-specific T lymphocytes)., Communication of the result of the QF-CMV to the clinician in charge - Cytomegalovirus Infections, Heart Transplantation | Not applicable | Recruiting | University Hospital, Grenoble | 288 | 2024-09-24 | 2024-10-01 |
| Differentiated Service Delivery for Pregnant and Postpartum Women Living With HIV and Their Infants Differentiated service delivery model - Hiv, Transmission Vertical | Not applicable | Completed | Indiana University | 278 | 2024-09-13 | 2026-05-28 |
| Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis observation - Sepsis, Sepsis Bacterial | Unknown | Sichuan Provincial People's Hospital | 300 | 2024-04-02 | 2024-07-09 | |
| Metagenomic Sequencing for the Identification of Pathogens in Febrile Neutropenic Patients Metagenomic diagnosis (mNGS, DISQVER) - Immunodepressed Patients (Hemato-oncology) | Not applicable | Terminated | Poitiers University Hospital | 184 | 2024-01-12 | 2026-08-25 |
| Enhanced Virologic Monitoring for Pregnant and Postpartum Women With HIV Enhanced virologic monitoring - HIV Infections, Viremia | Not applicable | Completed | University of California, San Francisco | 550 | 2023-05-08 | 2025-08-14 |
| Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections IVIG - Viremia, Bacteremia | Phase 4 | Unknown | Shanghai Changzheng Hospital | 40 | 2023-04-01 | 2023-04-05 |
| Trial to Model Primary, Secondary, and Tertiary Dengue Using a Monovalent Vaccine rDEN3Δ30/31-7164 - Response To Dengue Exposure | Phase 1 | Completed | National Institutes of Health Clinical Center (CC) | 127 | 2023-03-07 | 2026-06-16 |
| The Immunostimulatory Effects of Gentamicin Gentamicin, Placebo - Healthy Volunteers | Phase 2 | Terminated | Singapore General Hospital | 33 | 2022-05-11 | 2024-05-16 |
| Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients COVID-19 Respiratory Infection | Unknown | University Hospital Hradec Kralove | 30 | 2021-04-01 | 2024-05-10 | |
| Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes Stool and Blood Specimen Collection, Follow-up Medical Record Review - Congenital Heart Disease, Viremia | Not applicable | Completed | Washington University School of Medicine | 114 | 2021-02-01 | 2025-12-24 |
| Convalescent Plasma for Treatment of COVID-19 SARS-CoV-2 convalescent plasma, Standard of care - Covid19 | Phase 2 / Phase 3 | Completed | Joakim Dillner | 59 | 2020-12-03 | 2022-02-09 |
| PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01) [89]Zr-DFO-VRC-HIVMAB060-00-AB - HIV-1-infection | Phase 1 | Recruiting | University of California, San Francisco | 30 | 2018-11-01 | 2025-06-05 |
| Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission Tenofovir Disoproxil Fumarate (TDF) 300 mg oral daily. - Hepatitis B Infection, Congenital Malformation | Phase 4 | Unknown | New Discovery LLC | 280 | 2018-06-10 | 2019-12-12 |
| Validation of a Proteomic Signature and Assessment of Viremia in Children With Fever Without Source Infectious Disease, Fever | Completed | MeMed Diagnostics Ltd. | 206 | 2015-11-01 | 2023-01-06 | |
| Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection Dolutegravir 50 mg, Lamivudine 300 mg, Abacavir 600 mg - HIV, Acute HIV Infection | Not applicable | Completed | University of North Carolina, Chapel Hill | 40 | 2015-09-01 | 2021-11-22 |
| Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR) Protease inhibitor, Isentress® (raltegravir), Counseling arm - HIV-1 Infection, Treatment Resistant Disorders | Phase 3 | Terminated | ANRS, Emerging Infectious Diseases | 4 | 2014-12-01 | 2015-10-12 |
Showing 20 of 39. Sign in to see all of them.
HIV Infections (10) · Acquired Immunodeficiency Syndrome (5) · COVID-19 (3) · Cytomegalovirus Infections (3) · Hepatitis B (3) · Persistent Infection (3) · AIDS-Related Complex (2) · Bacteremia (2) · Communicable Diseases (2) · Fever (2) · Patient Acceptance of Health Care (2) · Virus Diseases (2) · Adenoviridae Infections (1) · Congenital Abnormalities (1)
Infections (39) · Inflammation (39) · Pathologic Processes (39) · Pathological Conditions, Signs and Symptoms (39) · Systemic Inflammatory Response Syndrome (39) · Sepsis (38) · Virus Diseases (37) · RNA Virus Infections (19) · Blood-Borne Infections (17) · Communicable Diseases (17) · Immune System Diseases (15) · Immunologic Deficiency Syndromes (13) · Urogenital Diseases (13) · Genital Diseases (12) · Lentivirus Infections (12)
Lamivudine (2) · Tenofovir (2) · Valganciclovir (2) · Antiretroviral Therapy, Highly Active (1) · Atorvastatin (1) · Blood Specimen Collection (1) · Bronchoalveolar Lavage (1) · COVID-19 Serotherapy (1) · Darunavir (1) · Defecation (1) · Fees and Charges (1) · Foscarnet (1) · Ganciclovir (1) · Gentamicins (1) · Hepatitis B Vaccines (1)
National Institute of Allergy and Infectious Diseases (NIAID) (8) · Indiana University (2) · New Discovery LLC (2) · University College, London (2) · University of California, San Francisco (2) · ANRS, Emerging Infectious Diseases (1) · Astellas Pharma Inc (1) · Cairo University (1) · Changzheng-Cinkate (1) · Children's Hospital of Philadelphia (1) · Community Research Initiative of New England (1) · Emory University (1) · Hua Zhang (1) · Joakim Dillner (1) · Mahidol University (1)
United States (19) · China (3) · France (3) · Kenya (3) · Puerto Rico (2) · United Kingdom (2) · Czechia (1) · Singapore (1) · Sweden (1) · Switzerland (1)
Calvin Q Pan, MD (2) · Erhei Dai, MD (2) · Para MF (2) · Abdel Rahaman Zekry, PhD (1) · Alejo Erice (1) · AnnMarie Liapakis, MD (1) · Caitlin Elgarten, MD, MSCE (1) · Calvin J Cohen, MD, MSc (1) · Camila D Odio, M.D. (1) · Cindy Gay, MD, MPH (1) · Collier A (1) · Coombs R (1) · Dalia Omran, MD (1) · David A. Wohl, MD (1) · Demeter L (1)
PMID 19632953, PMID 21148499, PMID 23208880, PMID 24699474, PMID 27305192, PMID 27799299, PMID 31462437, PMID 33789963, PMID 34880010, PMID 35264559, PMID 37221466, PMID 38700045, PMID 39540799, PMID 39807668, PMID 39843376, PMID 40831520, PMID 41432869
2014 (1), K01MH119910 (1), K23HD105495 (1), K23HD109056 (1)